North America Organoid Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), and Type (Instruments, Consumables, and Services)

No. of Pages: 90    |    Report Code: TIPRE00018845    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Organoid Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       North America Key Insights

2.2       North America Market Attractiveness

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           North America Organoids Market Landscape

4.1       Overview

4.2       North America PEST Analysis

5.           North America Organoids Market - Key Industry Dynamics

5.1       Key Market Drivers:

5.1.1         Increasing Demand for Tumor Modeling and Biobanking

5.1.2         Growing Adoption of Personalized Drugs

5.1.3         Rising Focus on Developing Alternatives for Animal Testing Models

5.2       Key Market Restraints:

5.2.1         Issues Related to Incorporation of Organoids into Existing Workflows

5.2.2         Dearth of Skilled Professionals

5.3       Key Market Opportunities:

5.3.1         Focus on Drug Discovery Activities

5.4       Future Trends:

5.4.1         Combining Organoid with Organ-On-A-Chip

5.5       Impact Analysis:

6.           Organoids Market – North America Market Analysis

6.1       North America Organoids Market Revenue (US$ Mn), 2022 – 2030

7.           North America Organoids Market – Revenue and Forecast to 2030 – by Organ Type

7.1       Overview

7.2       North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)

7.3       Stomach

7.3.1         Overview

7.3.2         Stomach: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Intestine

7.4.1         Overview

7.4.2         Intestine: North America Organoids Market – Revenue and Forecast to 2030  (US$ Million)

7.4.3

7.5       Liver

7.5.1         Overview

7.5.2         Liver: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

7.6       Pancreas

7.6.1         Overview

7.6.2         Pancreas: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Lung

7.7.1         Overview

7.7.2         Lung: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Brain

7.8.1         Overview

7.8.2         Brain: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

7.9       Kidney

7.9.1         Overview

7.9.2         Kidney: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

7.10     Others

7.10.1       Overview

7.10.2       Others: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.           North America Organoids Market – Revenue and Forecast to 2030 – by Application

8.1       Overview

8.2       North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)

8.3       Developmental Biology

8.3.1         Overview

8.3.2         Developmental Biology: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Disease Pathology of Infectious Disease

8.4.1         Overview

8.4.2         Disease Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.5       Regenerative Medicine

8.5.1         Overview

8.5.2         Regenerative Medicine: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.6       Drug Toxicity and Efficacy Testing

8.6.1         Overview

8.6.2         Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.7       Drug Discovery and Personalized Medicine

8.7.1         Overview

8.7.2         Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Others

8.8.1         Overview

8.8.2         Others: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

9.           North America Organoids Market – Revenue and Forecast to 2030 – by Source

9.1       Overview

9.2       North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)

9.3       Pluripotent Stem Cells

9.3.1         Overview

9.3.2         Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Organ-specific Adult Stem Cells

9.4.1         Overview

9.4.2         Organ-specific Adult Stem Cells: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.        North America Organoids Market – Revenue and Forecast to 2030 – by Type

10.1     Overview

10.2     North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)

10.3     Instruments

10.3.1       Overview

10.3.2       Instruments: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.4     Consumables

10.4.1       Overview

10.4.2       Consumables: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.5     Services

10.5.1       Overview

10.5.2       Services: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

11.        North America Organoids Market - Country Analysis

11.1     North America: Overview

11.1.1       North America Organoids Market, by Country

11.1.1.1          US

11.1.1.1.1        Overview

11.1.1.1.2        US Organoids Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.1.3        US Organoids Market, by Organ Type

11.1.1.1.4        US Organoids Market, by Application

11.1.1.1.5        US Organoids Market, by Source

11.1.1.1.6        US Organoids Market, by Type

11.1.1.2          Canada

11.1.1.2.1        Overview

11.1.1.2.2        Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.3        Canada Organoids Market, by Organ Type

11.1.1.2.4        Canada Organoids Market, by Application

11.1.1.2.5        Canada Organoids Market, by Source

11.1.1.2.6        Canada Organoids Market, by Type

11.1.1.3          Mexico

11.1.1.3.1        Overview

11.1.1.3.2        Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.3        Mexico Organoids Market, by Organ Type

11.1.1.3.4        Mexico Organoids Market, by Application

11.1.1.3.5        Mexico Organoids Market, by Source

11.1.1.3.6        Mexico Organoids Market, by Type

12.        Pre & Post COVID-19 Impact

12.1     Pre & Post Covid-19 Impact

13.        North America Organoids Market Industry Landscape

13.1     Overview

13.2     Growth Strategies Done by the Companies in the Market, (%)

13.3     Organic Developments

13.3.1       Overview

13.4     Inorganic Developments

13.4.1       Overview

14.        North America Organoids Market, Key Company Profiles

14.1     STEMCELL Technologies Inc.

14.1.1       Key Facts

14.1.2       Business Description

14.1.3       Products and Services

14.1.4       Financial Overview

14.1.5       SWOT Analysis

14.1.6       Key Developments

14.2     Cellesce Ltd

14.2.1       Key Facts

14.2.2       Business Description

14.2.3       Products and Services

14.2.4       Financial Overview

14.2.5       SWOT Analysis

14.2.6       Key Developments

14.3     Organoid Therapeutics

14.3.1       Key Facts

14.3.2       Business Description

14.3.3       Products and Services

14.3.4       Financial Overview

14.3.5       SWOT Analysis

14.3.6       Key Developments

14.4     3Dnamics Inc.

14.4.1       Key Facts

14.4.2       Business Description

14.4.3       Products and Services

14.4.4       Financial Overview

14.4.5       SWOT Analysis

14.4.6       Key Developments

14.5     Thermo Fisher Scientific Inc

14.5.1       Key Facts

14.5.2       Business Description

14.5.3       Products and Services

14.5.4       Financial Overview

14.5.5       SWOT Analysis

14.5.6       Key Developments

14.6     Merck KGaA

14.6.1       Key Facts

14.6.2       Business Description

14.6.3       Products and Services

14.6.4       Financial Overview

14.6.5       SWOT Analysis

14.6.6       Key Developments

14.7     InSphero

14.7.1    Key Facts

14.7.2    Business Description

14.7.3    Products and Services

14.7.4    Financial Overview

14.7.5    SWOT Analysis

14.7.6    Key Developments

15.        Appendix

15.1     About Us

15.2     Glossary of Terms

 

 

 

LIST OF TABLES

Table 1.             North America Organoids Market Segmentation

Table 2.             US Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type

Table 3.             US Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application

Table 4.             US Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source

Table 5.             US Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type

Table 6.             Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type

Table 7.             Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application

Table 8.             Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source

Table 9.             Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type

Table 10.          Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type

Table 11.          Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application

Table 12.          Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source

Table 13.          Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms, North America Organoids Market

 

 

LIST OF FIGURES

Figure 1.           North America Organoids Market Segmentation, By Country

Figure 2.           North America - PEST Analysis

Figure 3.           North America Organoids Market - Key Industry Dynamics

Figure 4.           Impact Analysis of Drivers and Restraints

Figure 5.           North America Organoids Market Revenue (US$ Mn), 2022 – 2030

Figure 6.           North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)

Figure 7.           Stomach: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Intestine: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Liver: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.        Pancreas: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Lung: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Brain: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Kidney: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        Others: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)

Figure 16.        Developmental Biology: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Disease Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Regenerative Medicine: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Others: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)

Figure 23.        Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Organ-specific Adult Stem Cells: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)

Figure 26.        Instruments: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        Consumables: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        Services: North America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Organoids Market, 2022 (US$Mn)

Figure 30.        North America Organoids Market, By Key Countries, 2022 And 2030 (%)

Figure 31.        US Organoids Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32.        Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)

Figure 33.        Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)

Figure 34.        Pre & Post Covid-19 Impact

Figure 35.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - North America Organoid Market

  1. STEMCELL Technologies Inc
  2. Cellesce
  3. Organoid Therapeutics
  4. 3Dnamics Inc
  5. Thermo Fisher Scientific Inc
  6. Merck KGaA
  7. InSphero